- Home
- SIM vs SLNO Comparison
SIM vs SLNO Comparison
Compare SIM & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIM
- SLNO
- Stock Information
- Founded
- SIM 1969
- SLNO 1999
- Country
- SIM Mexico
- SLNO United States
- Employees
- SIM N/A
- SLNO N/A
- Industry
- SIM Steel/Iron Ore
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SIM Industrials
- SLNO Health Care
- Exchange
- SIM Nasdaq
- SLNO Nasdaq
- Market Cap
- SIM 3.8B
- SLNO 3.2B
- IPO Year
- SIM 1993
- SLNO 2014
- Fundamental
- Price
- SIM $27.00
- SLNO $75.01
- Analyst Decision
- SIM
- SLNO Strong Buy
- Analyst Count
- SIM 0
- SLNO 9
- Target Price
- SIM N/A
- SLNO $103.33
- AVG Volume (30 Days)
- SIM 538.0
- SLNO 846.3K
- Earning Date
- SIM 04-30-2025
- SLNO 05-07-2025
- Dividend Yield
- SIM N/A
- SLNO N/A
- EPS Growth
- SIM 122.92
- SLNO N/A
- EPS
- SIM 3.34
- SLNO N/A
- Revenue
- SIM $1,641,713,837.00
- SLNO N/A
- Revenue This Year
- SIM N/A
- SLNO N/A
- Revenue Next Year
- SIM N/A
- SLNO N/A
- P/E Ratio
- SIM $8.09
- SLNO N/A
- Revenue Growth
- SIM N/A
- SLNO N/A
- 52 Week Low
- SIM $22.15
- SLNO $36.93
- 52 Week High
- SIM $33.78
- SLNO $80.91
- Technical
- Relative Strength Index (RSI)
- SIM 51.60
- SLNO 58.68
- Support Level
- SIM $26.40
- SLNO $71.19
- Resistance Level
- SIM $29.00
- SLNO $79.17
- Average True Range (ATR)
- SIM 0.23
- SLNO 3.18
- MACD
- SIM -0.11
- SLNO -0.70
- Stochastic Oscillator
- SIM 23.08
- SLNO 39.01
About SIM Grupo Simec S.A.B. de C.V.
Grupo Simec SAB de CV is a diversified manufacturer, processor, and distributor of SBQ steel and structural steel products with production and commercial operations. The group's SBQ products are used across a range of engineered end-user applications, including axles, hubs, and crankshafts for automobiles and light trucks, machine tools, and off-highway equipment. Its structural steel products are used in the non-residential construction market and other construction applications. Its segments are Mexico, Brazil, and the United States.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.